or Try an Advanced Search...

    Technical Analysis for SNGX - Soligenix, Inc.

    Grade Last Price % Change Price Change
    F 3.43 -2.28% -0.08
    SNGX closed down 0.57 percent on Wednesday, November 20, 2024, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SNGX trend table...
    Date Alert Name Type % Chg
    Lizard Bullish Bullish Day Trade Setup -2.28%
    Bollinger Band Squeeze Range Contraction -2.28%
    NR7 Range Contraction -2.28%
    Doji - Bullish? Reversal -2.28%
    Bollinger Band Squeeze Range Contraction -2.83%
    Outside Day Range Expansion -2.83%
    Bollinger Band Squeeze Range Contraction -2.56%
    NR7 Range Contraction -2.56%
    Doji - Bullish? Reversal -2.56%
    20 DMA Resistance Bearish -3.11%
    Older End-of-Day Signals for SNGX ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support 25 minutes ago
    Down 3% about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SNGX Chart by TradingView
    Basic chart:

    Profile

    Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ' (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Treatment Radiation Gastrointestinal Therapeutic Products Toxins Biodefense Proteins Gastrointestinal Disease Biological Warfare Lectins Biotherapeutic Products

    Is SNGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
    Nov 14 Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
    Nov 14 Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
    Nov 11 SNGX: Phase 3 CTCL Trial to Initiate Before End of 2024
    Oct 24 Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
    Oct 22 Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
    Oct 16 Soligenix Invited to Present at Upcoming Investor Conferences
    Oct 7 HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
    Oct 3 SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…
    Oct 3 Soligenix enters partnership with Sterling Pharma
    See more SNGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 32.0
    52 Week Low 1.8301
    Average Volume 131,446
    200-Day Moving Average 5.85
    50-Day Moving Average 3.76
    20-Day Moving Average 3.65
    10-Day Moving Average 3.56
    Average True Range 0.23
    RSI (14) 44.44
    ADX 20.71
    +DI 16.83
    -DI 14.39
    Chandelier Exit (Long, 3 ATRs) 3.30
    Chandelier Exit (Short, 3 ATRs) 4.10
    Upper Bollinger Bands 3.92
    Lower Bollinger Band 3.38
    Percent B (%b) 0.24
    BandWidth 14.97
    MACD Line -0.07
    MACD Signal Line -0.06
    MACD Histogram -0.0048
    Fundamentals Value
    Market Cap 36.94 Million
    Num Shares 10.5 Million
    EPS -1.46
    Price-to-Earnings (P/E) Ratio -2.40
    Price-to-Sales 7.44
    Price-to-Book 1.65
    PEG Ratio -1.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.69
    Resistance 3 (R3) 3.68 3.60 3.66
    Resistance 2 (R2) 3.60 3.56 3.61 3.65
    Resistance 1 (R1) 3.56 3.53 3.57 3.57 3.64
    Pivot Point 3.48 3.48 3.49 3.49 3.48
    Support 1 (S1) 3.44 3.44 3.45 3.45 3.38
    Support 2 (S2) 3.36 3.41 3.37 3.37
    Support 3 (S3) 3.32 3.36 3.36
    Support 4 (S4) 3.33